LT2961481T - Vietinė antimikrobinė dermatologinė kompozicija - Google Patents

Vietinė antimikrobinė dermatologinė kompozicija

Info

Publication number
LT2961481T
LT2961481T LTEP14718638.1T LT14718638T LT2961481T LT 2961481 T LT2961481 T LT 2961481T LT 14718638 T LT14718638 T LT 14718638T LT 2961481 T LT2961481 T LT 2961481T
Authority
LT
Lithuania
Prior art keywords
dermatological composition
topical antimicrobial
antimicrobial dermatological
topical
composition
Prior art date
Application number
LTEP14718638.1T
Other languages
English (en)
Inventor
Jean-Marie Lefevre
Jacques Peyrot
Jean-Claude Allart
Original Assignee
Laboratoires Thea S.A.S.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratoires Thea S.A.S. filed Critical Laboratoires Thea S.A.S.
Publication of LT2961481T publication Critical patent/LT2961481T/lt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
LTEP14718638.1T 2013-02-28 2014-02-24 Vietinė antimikrobinė dermatologinė kompozicija LT2961481T (lt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1351766A FR3002452B1 (fr) 2013-02-28 2013-02-28 Composition dermatologique antimicrobienne topique
PCT/FR2014/050383 WO2014131974A1 (fr) 2013-02-28 2014-02-24 Composition dermatologique antimicrobienne topique

Publications (1)

Publication Number Publication Date
LT2961481T true LT2961481T (lt) 2017-10-25

Family

ID=48613829

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP14718638.1T LT2961481T (lt) 2013-02-28 2014-02-24 Vietinė antimikrobinė dermatologinė kompozicija

Country Status (23)

Country Link
US (1) US20150343014A1 (lt)
EP (2) EP2961481B1 (lt)
JP (1) JP6440637B2 (lt)
KR (1) KR102193453B1 (lt)
AR (1) AR094976A1 (lt)
BR (1) BR112015020405B1 (lt)
CA (1) CA2897518C (lt)
CY (1) CY1119431T1 (lt)
DK (1) DK2961481T3 (lt)
ES (1) ES2641492T3 (lt)
FR (1) FR3002452B1 (lt)
HR (1) HRP20171446T1 (lt)
HU (1) HUE034470T2 (lt)
LT (1) LT2961481T (lt)
MA (1) MA38344B1 (lt)
MX (1) MX352060B (lt)
PL (1) PL2961481T3 (lt)
PT (1) PT2961481T (lt)
RU (1) RU2668827C2 (lt)
SI (1) SI2961481T1 (lt)
TN (1) TN2015000282A1 (lt)
UA (1) UA115894C2 (lt)
WO (1) WO2014131974A1 (lt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016535781A (ja) 2013-11-03 2016-11-17 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 経皮薬物送達のためのイオン性液体
WO2017098474A1 (en) * 2015-12-09 2017-06-15 Universidade Do Minho Antimicrobial peptide-loaded hyaluronic acid-based formulations, method of production and uses thereof
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
EP3503927A1 (en) * 2016-08-29 2019-07-03 The Regents of the University of California Topical formulations based on ionic species for skin treatment
JP7475018B2 (ja) * 2017-07-25 2024-04-26 ピアス株式会社 皮膚外用組成物
FR3132633B1 (fr) * 2022-02-14 2024-04-12 Thea Lab Composition topique pour son utilisation dans le traitement des blépharites.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU600483B2 (en) 1986-03-14 1990-08-16 Bio-Technology General Corporation Heavy metal salts of hyaluronic acid
SE9400036D0 (sv) 1994-01-10 1994-01-10 Pharmacia Ab Low modecular weight hyaluronic acid
CA2205771C (en) * 1997-05-22 2002-05-14 Hyal Pharmaceutical Corporation Improved delivery of disease modifiers
US6809181B2 (en) 2000-06-01 2004-10-26 University Of Iowa Research Foundation Human beta-defensin-3 (HBD-3), a highly cationic beta-defensin antimicrobial peptide
GB0103877D0 (en) * 2001-02-16 2001-04-04 King S College London Novel Drug Delivery system
SI20877A (sl) * 2001-03-21 2002-10-31 Kemijski inštitut Lipopeptidi, njihova priprava in njihova uporaba za inaktivacijo gram-negativnih bakterij, gram-pozitivnih bakterij in za nevtralizacijo endotoksinov
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
CA2457885A1 (en) * 2001-08-24 2003-03-06 Micrologix Biotech Inc. Antimicrobial and anti-inflammatory peptides
US20050196370A1 (en) * 2003-03-18 2005-09-08 Zhi-Jian Yu Stable ophthalmic oil-in-water emulsions with sodium hyaluronate for alleviating dry eye
JP4662932B2 (ja) * 2003-08-15 2011-03-30 ユニバーシティー オブ サウス フロリダ 試料からの病原体の捕獲およびアウリントリカルボン酸除去のための物質および方法
US20050118678A1 (en) * 2003-10-17 2005-06-02 Regents Of The University Of Minnesota Modified polypeptides with therapeutic activity and methods of use
CA2597191C (en) * 2005-02-09 2014-04-01 Helix Biomedix Inc. Antimicrobial hexapeptides
CA2610791C (en) * 2005-06-08 2015-12-01 Cangene Corporation Hyaluronic acid binding peptides enhance host defense against pathogenic bacteria
FR2894827B1 (fr) 2005-12-21 2010-10-29 Galderma Res & Dev Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation,et leurs utilisations
US8394782B2 (en) 2007-11-30 2013-03-12 Allergan, Inc. Polysaccharide gel formulation having increased longevity
US20090258045A1 (en) * 2008-03-18 2009-10-15 Massachusetts Institute Of Technology Structures including antimicrobial peptides
CN102271658B (zh) * 2009-01-13 2013-06-12 佩加马公司 用于治疗伤口、瘢痕、外科手术后粘连形成的含有透明质酸的组合物
WO2010109284A1 (en) * 2009-03-27 2010-09-30 University Of Manitoba Antimicrobial cationic lipo-beta-peptides
FR2954945B1 (fr) 2010-01-04 2012-01-06 Oreal Composition cosmetique ou dermatologique, procede de traitement cosmetique et derive d'acide hyaluronique
CA2790682C (en) * 2010-03-03 2020-11-24 Neocutis Sa Compositions and methods for the treatment of skin diseases and disorders using antimicrobial peptide sequestering compounds
CN102552889A (zh) * 2010-12-27 2012-07-11 上海高科联合生物技术研发有限公司 一种生物杀菌滴眼液制剂
RU2460532C1 (ru) * 2011-04-28 2012-09-10 Учреждение Российской академии наук Институт энергетических проблем химической физики РАН Препарат, ускоряющий ранозаживление
FR2978664B1 (fr) * 2011-08-04 2014-01-10 Petcare Innovation Composition antiseptique

Also Published As

Publication number Publication date
RU2668827C2 (ru) 2018-10-02
AR094976A1 (es) 2015-09-09
HUE034470T2 (en) 2018-02-28
MX2015010606A (es) 2016-04-21
BR112015020405B1 (pt) 2020-07-07
EP2961481A1 (fr) 2016-01-06
CY1119431T1 (el) 2018-03-07
MA38344B1 (fr) 2018-11-30
JP2016510017A (ja) 2016-04-04
FR3002452B1 (fr) 2016-02-12
MX352060B (es) 2017-11-08
RU2015140996A (ru) 2017-04-06
BR112015020405A2 (pt) 2017-07-18
KR102193453B1 (ko) 2020-12-21
RU2015140996A3 (lt) 2018-03-12
ES2641492T3 (es) 2017-11-10
CA2897518C (fr) 2021-02-16
KR20150134325A (ko) 2015-12-01
UA115894C2 (uk) 2018-01-10
TN2015000282A1 (fr) 2016-10-03
US20150343014A1 (en) 2015-12-03
HRP20171446T1 (hr) 2017-12-29
EP3287171A1 (fr) 2018-02-28
SI2961481T1 (en) 2018-01-31
DK2961481T3 (en) 2017-10-09
WO2014131974A1 (fr) 2014-09-04
CA2897518A1 (fr) 2014-09-04
PT2961481T (pt) 2017-08-18
PL2961481T3 (pl) 2018-01-31
JP6440637B2 (ja) 2018-12-19
MA38344A1 (fr) 2018-03-30
EP2961481B1 (fr) 2017-06-28
FR3002452A1 (fr) 2014-08-29

Similar Documents

Publication Publication Date Title
HK1218261A1 (zh) 抗微生物製劑的局部使用
GB201309406D0 (en) Topical composition
PL2774481T3 (pl) Kompozycje przeciwdrobnoustrojowe
EP2968871A4 (en) NEGATIVE PRESSURE TOPICAL DRESSINGS FOR SURGICAL INCISIONS, SURGICAL ADJUVANTS, HYBRIDS AND COMPOSITES
EP3046540A4 (en) Antimicrobial compositions
SG10201913330SA (en) Hypertonic antimicrobial therapeutic compositions
IL237035A0 (en) Antibacterial compound for external use
EP3065547A4 (en) Biscationic and triscationic amphiles as antimicrobial agents
PL3060040T3 (pl) Kompozycje przeciwdrobnoustrojowe
PL2991484T3 (pl) Synergiczny preparat przeciwdrobnoustrojowy
ZA201508595B (en) Antimicrobial compounds and compositions
EP2983678A4 (en) Anti-microbial composition
PL2961481T3 (pl) Miejscowa, przeciwdrobnoustrojowa kompozycja dermatologiczna
FR3001392B1 (fr) Composition dermatologique amelioree
GB201320932D0 (en) Topical pharmaceutical composition
HK1213813A1 (zh) 種含埃克替尼的皮膚外用藥物組合物及其應用
HUE062405T2 (hu) Antimikrobiális készítmény
EP3081210A4 (en) Cosmetic composition
HK1213772A1 (zh) 含有人參皂苷 的皮膚外用劑組合物
ZA201600535B (en) Cosmetic composition
HK1212918A1 (zh) 含有人參皂苷 的皮膚外用劑組合物
EP2983717A4 (en) TOPICAL NUTRACEUTICAL COMPOSITION
ZA201502882B (en) Topical parasiticidal formulation
EP2943067A4 (en) FUNGICIDE COMPOSITION
HK1217286A1 (zh) 含有人參皂苷 的皮膚外用劑組合物